Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for American Healthcare REIT (AHR) over the last 10 years, with Q3 2025 value amounting to $49.2 million.

  • American Healthcare REIT's Depreciation & Amortization (CF) rose 1115.36% to $49.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $179.2 million, marking a year-over-year increase of 165.35%. This contributed to the annual value of $179.2 million for FY2024, which is 186.85% down from last year.
  • As of Q3 2025, American Healthcare REIT's Depreciation & Amortization (CF) stood at $49.2 million, which was up 1115.36% from $41.9 million recorded in Q2 2025.
  • American Healthcare REIT's 5-year Depreciation & Amortization (CF) high stood at $54.8 million for Q4 2021, and its period low was $25.7 million during Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $41.9 million, with a median of $44.0 million in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 10786.17% in 2021, then tumbled by 1740.88% in 2022.
  • Quarter analysis of 5 years shows American Healthcare REIT's Depreciation & Amortization (CF) stood at $54.8 million in 2021, then dropped by 17.41% to $45.2 million in 2022, then decreased by 2.83% to $44.0 million in 2023, then rose by 6.72% to $46.9 million in 2024, then increased by 4.83% to $49.2 million in 2025.
  • Its last three reported values are $49.2 million in Q3 2025, $41.9 million for Q2 2025, and $41.1 million during Q1 2025.